BNP Paribas Financial Markets decreased its position in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 26.2% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 41,728 shares of the business services provider's stock after selling 14,793 shares during the period. BNP Paribas Financial Markets owned about 0.08% of Exponent worth $4,810,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently made changes to their positions in EXPO. Kayne Anderson Rudnick Investment Management LLC grew its holdings in shares of Exponent by 6.5% in the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 4,640,600 shares of the business services provider's stock worth $441,414,000 after purchasing an additional 284,179 shares during the last quarter. Assenagon Asset Management S.A. bought a new stake in Exponent in the second quarter valued at $22,050,000. International Assets Investment Management LLC bought a new stake in Exponent in the third quarter valued at $11,261,000. Conestoga Capital Advisors LLC boosted its holdings in Exponent by 2.8% in the second quarter. Conestoga Capital Advisors LLC now owns 2,763,260 shares of the business services provider's stock valued at $262,841,000 after acquiring an additional 75,909 shares in the last quarter. Finally, TimesSquare Capital Management LLC boosted its holdings in Exponent by 21.1% in the third quarter. TimesSquare Capital Management LLC now owns 280,090 shares of the business services provider's stock valued at $32,289,000 after acquiring an additional 48,859 shares in the last quarter. Institutional investors own 92.37% of the company's stock.
Exponent Price Performance
NASDAQ:EXPO traded down $0.59 during trading hours on Wednesday, hitting $98.07. The company had a trading volume of 395,050 shares, compared to its average volume of 243,473. The company has a market capitalization of $4.98 billion, a PE ratio of 47.38 and a beta of 0.70. The stock has a 50-day moving average price of $104.73 and a 200 day moving average price of $102.38. Exponent, Inc. has a 52 week low of $68.70 and a 52 week high of $115.75.
Exponent Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, December 20th. Investors of record on Friday, December 6th will be issued a $0.28 dividend. This represents a $1.12 annualized dividend and a yield of 1.14%. The ex-dividend date of this dividend is Friday, December 6th. Exponent's dividend payout ratio (DPR) is currently 54.11%.
Insider Activity at Exponent
In other Exponent news, Director Carol Lindstrom sold 1,039 shares of the firm's stock in a transaction on Monday, November 4th. The stock was sold at an average price of $96.32, for a total transaction of $100,076.48. Following the completion of the transaction, the director now owns 5,871 shares of the company's stock, valued at approximately $565,494.72. This trade represents a 15.04 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Paul R. Johnston sold 14,000 shares of the firm's stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $104.60, for a total value of $1,464,400.00. Following the transaction, the director now directly owns 80,742 shares of the company's stock, valued at $8,445,613.20. This represents a 14.78 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 30,339 shares of company stock worth $3,103,065 over the last quarter. Corporate insiders own 2.10% of the company's stock.
Exponent Company Profile
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Articles
Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.